GEN Exclusives

More »

GEN News Highlights

Back to Item »

Hutchinson, AstraZeneca Ink Deal for c-Met Inhibitor with $20M Up Front

Firms will share costs of developing Volitinib in China, with AstraZeneca shouldering expenses elsewhere.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Celebrities and Genetic Testing

Do you think celebrity announcements that they took a genetic test will generally increase the odds that more members of the public will undergo genetic testing?

More »